We previously developed a seven-gene prognostic and predictive assay for early-stage NSCLC (including ABCC4, CCL19, SLC39A8, CD27, FUT7, DAG1, and ZNF71) [44,78]. This evidence concerns the gene SLC39A8 and non-small cell lung carcinoma.